These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9588069)

  • 21. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 22. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of red cell distribution width in alcoholic and non-alcoholic liver cirrhosis.
    Milić S; Mikolasević I; Radić M; Hauser G; Stimac D
    Coll Antropol; 2011 Sep; 35 Suppl 2():335-8. PubMed ID: 22220466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumor necrosis factor family and and correlation with disease activity and response to treatment in hairy cell leukemia.
    Barak V; Nisman B; Polliack A
    Eur J Haematol; 1999 Feb; 62(2):71-5. PubMed ID: 10052708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO
    Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
    Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
    Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
    [No Abstract]   [Full Text] [Related]  

  • 27. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
    Siegal FP; Shodell M; Shah K; Drake D; Hoffman M; Sawitsky A; Janson D; Fitzgerald-Bocarsly P; Rai KR
    Leukemia; 1994 Sep; 8(9):1474-9. PubMed ID: 7916389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE; Frassoldati A
    Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hairy cell leukemia: long-term results in a developing country.
    Ruiz-Delgado GJ; Tarín-Arzaga LC; Alarcón-Urdaneta C; Calderón-García J; Gómez-Almaguer D; Ruiz-Argüelles GJ
    Hematology; 2012 May; 17(3):140-3. PubMed ID: 22664112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
    Arun B; Curti BD; Longo DL; Stevens D; Alvord WG; Gause BL; Watson T; Kopp WC; Janik JE
    Cancer J Sci Am; 2000; 6(1):21-4. PubMed ID: 10696734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.
    Ozer H; Golomb HM; Zimmerman H; Spiegel RJ
    J Natl Cancer Inst; 1989 Apr; 81(8):594-602. PubMed ID: 2495367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G; Liliemark J
    Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-interferon in hairy cell leukemia: an initial Indian experience.
    Malhotra H; Advani SH; Gopal R; Saikia TK; Nadkarni KS; Pai VR; Nair CN
    J Assoc Physicians India; 1992 Mar; 40(3):159-61. PubMed ID: 1634479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
    Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
    Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.